ArticleEClinicalMedicine2025

Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial.

Yong Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.